DIVIS LABORATORIES
|
The Current P/S Ratio of DIVIS LABORATORIES is 20.10.
| Share Price | ₹8,500.0 | Aug 14,2026 |
| Market Cap | ₹225,675.0 Cr | |
| Sales-TTM | ₹11,230.0 Cr | TTM-Consolidated Results |
| Price/Sales | 20.10x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹225,675.0 Cr] as on Aug 14,2026
(/) Sales [ ₹11,230.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 20.10x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '20.10 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES
PS Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 13.11x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 13.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 16.34x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.
How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| DIVIS LABORATORIES | 11,230.0 | 20.10 | 225,675.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.71 | 461,848.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.71 | 184,109.0 |
| CIPLA LTD | 28,324.4 | 4.14 | 117,139.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.02 | 100,328.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.78 | 99,945.0 |
| LUPIN LTD | 29,966.6 | 3.41 | 102,192.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.98 | 113,715.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.73 | 95,397.6 |
| LAURUS LABS LTD | 7,269.6 | 13.49 | 98,064.0 |
| BIOCON LTD | 17,321.1 | 3.90 | 67,616.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.73x |
| Max industry PS | 20.10x |
| Median industry PS | 4.14x |
| Average industry PS | 7.36x |
You may also like the below Video Courses